Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation (CTOT-11).
Phase of Trial: Phase II
Latest Information Update: 14 Apr 2018
At a glance
- Drugs Rituximab (Primary)
- Indications Heart transplant rejection
- Focus Therapeutic Use
- Acronyms CTOT-11
- 14 Apr 2018 Results presented at the 38th Annual Meeting and Scientific Sessions of the International Society for Heart and Lung Transplantation
- 21 Nov 2012 Actual initiation date changed from Feb 2011 to Sep 2011 as reported by ClinicalTrials.gov.
- 14 Jun 2011 New trial record